Highlights:
- In a larger, randomized, controlled study, a common painkiller diclofenac has been linked to episodes of heart attacks and strokes compared to other painkillers.
- Researchers suggest not allowing diclofenac to be available over the counter, and add an appropriate warning about its potential risks when it is prescribed.
The painkiller diclofenac was associated with an increased
risk of cardiovascular events like heart attacks and strokes compared to use of
no drug, paracetamol, or other traditional
painkillers, says researchers from the
Aarhus University Hospital in Denmark.
The study is published in The BMJ.
Listen to this article
0:00/0:00
Anti-Inflammatory Medication for Seasonal Allergy
For long term benefits or for severe cases of seasonal allergy, anti-inflammatory medication in the form of corticosteroids, mast cell stabilizers and immunotherapy are preferred.
For long term benefits or for severe cases of seasonal allergy, anti-inflammatory medication in the form of corticosteroids, mast cell stabilizers and immunotherapy are preferred.
Advertisement
‘Individuals starting on the traditional painkiller diclofenac are showing a relative increased risk of major adverse heart problems prompting researchers to say that it is time to acknowledge diclofenac’s potential health risk and to reduce its use.’
Tweet it Now
Diclofenac is a common, widely used traditional non-steroidal anti-inflammatory drug, otherwise known as NSAID, used for treating pain and inflammation. However, until now, the cardiovascular risks of diclofenac and other traditional NSAIDs have not been compared in large randomized controlled trials.
Since it is available over the counter in most countries
that makes its cardiovascular risk of public health and vital clinical importance, the European
Medicines Agency has asked for a safety testing of diclofenac.
![Cardiovascular Risk Factors During Midlife Increase Risk of Dementia]( "Cardiovascular Risk Factors During Midlife Increase Risk of Dementia")
The results for an entire period of 10 years were obtained from the Danish national registry data for more than 6.3 million adults who had filled out prescription records continuously for at least a year before study entry in January 1996.
The average age of participants who initiated NSAIDs was 46 to 49 years, whereas it was 56 years for the participants who began paracetamol. The participants were divided into groups of people having low, moderate, and high baseline cardiovascular risk.
The results clearly pointed that starting diclofenac during the 10 year study period from 1996 to 2016 was linked to an increased rate of major adverse cardiovascular events like irregular heartbeat or flutter, ischemic stroke, heart failure, and heart attack within a month compared to starting ibuprofen or naproxen (traditional NSAIDs) or paracetamol.
The risk was seen in men and women of all ages and also at low strengths of diclofenac.
Compared to not having any NSAIDs, starting diclofenac caused an increased rate of cardiac death.
Starting diclofenac caused an increased risk of upper gastrointestinal bleeding compared to people who started without any NSAIDs and ibuprofen or paracetamol but not with naproxen.
Next, they analyzed the results based on baseline cardiovascular risk. Compared to ibuprofen starters, diclofenac starters had one, seven, and sixteen additional events among patients at low, moderate and high baseline risk respectively.
Compared to naproxen starters, diclofenac starters had one, seven, and ten additional events among patients at low, moderate and high baseline risk respectively.
Compared to paracetamol starters, diclofenac starters had three, eight, and one additional event among patients at low, moderate and high baseline risk respectively.
Compared to having no NSAIDs, diclofenac starters had four, fourteen, and thirty-nine additional events among patients at low, moderate and high baseline risk respectively.
Two points to note in this study are -
"Treatment of pain and inflammation with NSAIDs may be worthwhile for some patients to improve quality of life despite potential side effects," they write. "Considering its cardiovascular and gastrointestinal risks, however, there is little justification to initiate diclofenac treatment before other traditional NSAIDs," they conclude.
References :
Source: Medindia
Study - Examining Cardiovascular Risks of Initiating Diclofenac
The study estimated the cardiovascular risks among patients who started on diclofenac versus patients who did not use any NSAIDs, who used the traditional NSAIDs, and those who used paracetamol, a non-NSAID painkiller.
Cardiovascular Risk Factors During Midlife Increase Risk of Dementia
Midlife vascular health is important to prevent the risk of dementia. Cardiovascular risk factors such as diabetes, hypertension, and smoking can increase the risk.
Midlife vascular health is important to prevent the risk of dementia. Cardiovascular risk factors such as diabetes, hypertension, and smoking can increase the risk.
Advertisement
The results for an entire period of 10 years were obtained from the Danish national registry data for more than 6.3 million adults who had filled out prescription records continuously for at least a year before study entry in January 1996.
The average age of participants who initiated NSAIDs was 46 to 49 years, whereas it was 56 years for the participants who began paracetamol. The participants were divided into groups of people having low, moderate, and high baseline cardiovascular risk.
The results clearly pointed that starting diclofenac during the 10 year study period from 1996 to 2016 was linked to an increased rate of major adverse cardiovascular events like irregular heartbeat or flutter, ischemic stroke, heart failure, and heart attack within a month compared to starting ibuprofen or naproxen (traditional NSAIDs) or paracetamol.
The risk was seen in men and women of all ages and also at low strengths of diclofenac.
Compared to not having any NSAIDs, starting diclofenac caused an increased rate of cardiac death.
Starting diclofenac caused an increased risk of upper gastrointestinal bleeding compared to people who started without any NSAIDs and ibuprofen or paracetamol but not with naproxen.
Next, they analyzed the results based on baseline cardiovascular risk. Compared to ibuprofen starters, diclofenac starters had one, seven, and sixteen additional events among patients at low, moderate and high baseline risk respectively.
Compared to naproxen starters, diclofenac starters had one, seven, and ten additional events among patients at low, moderate and high baseline risk respectively.
Compared to paracetamol starters, diclofenac starters had three, eight, and one additional event among patients at low, moderate and high baseline risk respectively.
Compared to having no NSAIDs, diclofenac starters had four, fourteen, and thirty-nine additional events among patients at low, moderate and high baseline risk respectively.
Two points to note in this study are -
- # Although the relative risk (disease risk compared to other drugs) increases, the absolute risk (the risk that diclofenac will definitely cause cardiovascular events to happen) is low.
- Also, the study is observational, and we cannot conclude cause and effect.
"Treatment of pain and inflammation with NSAIDs may be worthwhile for some patients to improve quality of life despite potential side effects," they write. "Considering its cardiovascular and gastrointestinal risks, however, there is little justification to initiate diclofenac treatment before other traditional NSAIDs," they conclude.
References :
- NSAIDs: Do they increase my risk of heart attack and stroke? - (https://www.mayoclinic.org/diseases-conditions/heart-attack/expert-answers/nsaids-heart-attack-stroke/faq-20147557)
- NSAIDs and the Risk of Heart Problems and Stroke - (https://www.arthritis.org/living-with-arthritis/treatments/medication/drug-types/nsaids/nsaids-heart-attack-stroke-risk.php)
Source: Medindia
Heart Attack
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Advertisement
 Congestive Heart Failure Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump that can deliver oxygen rich blood to the body. | Advertisement
|
Advertisement
Recommended Reading
Latest Health In Focus
Explore how gut microbes and a new therapy called fecal microbiota transplant may transform the treatment of inflammatory bowel diseases (IBD).
Kerala passes amendment to its hospital protection act to safeguard doctors from violence, imposing stricter penalties. This ensures safety for medical professionals.
Exploring how an Artificial Intelligence system could be held liable for legal damages in case of adverse patient outcomes.
Tirazepatide is a brand-new drug that has a combined action on both diabetes and obesity is often recommended for weight loss due to its effective action.
Understanding how the National Medical Device Policy puts forth objectives and strategies to govern, develop and set standards for the industry.